Stockscreener 앱 받기
378.81
1.36%
5.10
전일 마감가:
$373.71
열려 있는:
$374.55
하루 거래량:
2.46M
Relative Volume:
0.86
시가총액:
$135.72B
수익:
$11.03B
순이익/손실:
$3.16B
주가수익비율:
43.42
EPS:
8.7251
순현금흐름:
$3.22B
1주 성능:
+7.21%
1개월 성능:
-11.35%
6개월 성능:
-22.40%
1년 성능:
-19.37%
1일 변동 폭
$372.63
$379.90
1주일 범위
$360.98
$379.90
52주 변동 폭
$328.57
$603.88
인튜이티브 서지컬 Stock (ISRG) Company Profile
명칭
Intuitive Surgical Inc
전화
(408) 523-2100
주소
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
378.81 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.86 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
71.81 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
211.94 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.23 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
인튜이티브 서지컬 Stock (ISRG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-07-23 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-06-09 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2025-06-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | 재확인 | Citigroup | Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-11-17 | 개시 | HSBC Securities | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-19 | 재확인 | BTIG Research | Buy |
| 2023-04-19 | 재확인 | BofA Securities | Buy |
| 2023-04-19 | 재확인 | Citigroup | Buy |
| 2023-04-19 | 재확인 | Evercore ISI | In-line |
| 2023-04-19 | 재확인 | JP Morgan | Overweight |
| 2023-04-19 | 재확인 | Morgan Stanley | Equal-Weight |
| 2023-04-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-19 | 재확인 | Raymond James | Outperform |
| 2023-04-19 | 재확인 | Stifel | Buy |
| 2023-04-19 | 재확인 | Truist | Buy |
| 2023-04-19 | 재확인 | Wells Fargo | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-23 | 개시 | William Blair | Outperform |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-13 | 개시 | Mizuho | Neutral |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-25 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | 다운그레이드 | Redburn | Buy → Neutral |
| 2022-01-21 | 재확인 | BTIG Research | Buy |
| 2022-01-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-21 | 재확인 | Deutsche Bank | Hold |
| 2022-01-21 | 재확인 | Evercore ISI | In-line |
| 2022-01-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-01-21 | 재확인 | Piper Sandler | Neutral |
| 2022-01-21 | 재확인 | Raymond James | Outperform |
| 2022-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2022-01-21 | 재확인 | Stifel | Buy |
| 2022-01-21 | 재확인 | UBS | Neutral |
| 2022-01-21 | 재확인 | Wells Fargo | Overweight |
| 2022-01-10 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-07-21 | 재확인 | BofA Securities | Neutral |
| 2021-07-21 | 재확인 | Citigroup | Buy |
| 2021-07-21 | 재확인 | JP Morgan | Overweight |
| 2021-07-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-07-21 | 재확인 | Piper Sandler | Neutral |
| 2021-07-21 | 재확인 | SVB Leerink | Mkt Perform |
| 2021-07-21 | 재확인 | Stifel | Buy |
| 2021-07-21 | 재확인 | UBS | Neutral |
| 2021-07-21 | 재확인 | Wells Fargo | Overweight |
| 2021-07-14 | 재확인 | Goldman | Buy |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-04-21 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2021-04-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2020-12-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | 개시 | Argus | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-07-20 | 재확인 | Bernstein | Outperform |
| 2020-04-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
| 2020-04-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-04-01 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2020-01-27 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-12-12 | 재확인 | Wells Fargo | Outperform |
| 2019-11-21 | 개시 | Oppenheimer | Perform |
| 2019-07-19 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-22 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-02 | 개시 | Deutsche Bank | Buy |
| 2018-10-31 | 재확인 | Piper Jaffray | Overweight |
| 2018-10-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
모두보기
인튜이티브 서지컬 주식(ISRG)의 최신 뉴스
ISRG Q2 Earnings Call Signals Durable Demand & U.S. Caution - The Globe and Mail
Tuesday's move in Intuitive Surgical is probably more than short covering. How to play it using options - CNBC
UBS Upgrades Intuitive Surgical to Buy From Neutral, Cuts Price Target to $500 From $550 - marketscreener.com
Intuitive Surgical Fell 37% to $355 With This Wall Street Pro Is Calling for $685 - 24/7 Wall St.
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls - Yahoo Finance
UBS starts medtech coverage, favors Intuitive Surgical and Enovis - Investing.com
Here's Exactly Why Wall Street Thinks Intuitive Surgical Stock Could Soar 102% Over the Next 12 Months - The Motley Fool
UBS initiates Intuitive Surgical stock coverage with buy rating - Investing.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Boston Scientific, Clorox, CrowdStrike, Exxon Mobil, Honeywell International, Intuit, Intuitive Surgical, Levi Strauss, and More - 24/7 Wall St.
Here's Exactly Why Wall Street Thinks Intuitive Surgical Stock Could Soar 102% Over the Next 12 Months - The Motley Fool
UBS initiates Intuitive Surgical stock coverage with buy rating By Investing.com - Investing.com Canada
UBS Upgrades Intuitive Surgical to Buy From Neutral, Adjusts Price Target to $500 From $550 - marketscreener.com
Why Are Intuitive Surgical (ISRG) Shares Soaring Today - Yahoo Finance
How Intuitive Surgical Inc. (ISRG) Affects Rotational Strategy Timing - Stock Traders Daily
Intuitive, Deion Sanders collab to raise surgical awareness - MassDevice
Is It Too Late to Buy Intuitive Surgical Inc (ISRG) After 5.7% R - GuruFocus
Intuitive Surgical Tightens Shareholder Governance and Proxy Rules - TipRanks
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical Inc Stock (ISRG) Closed Up by 5.71% on Jul 27: What Signal Does It Send? - TradingKey
Intuitive Surgical (ISRG) updates bylaws on director nominations and proxy rules - Stock Titan
UnitedHealth Group Incorporated (UNH) and Intuitive Surgical, Inc. (ISRG) Just Showed Why Beating Estimates Isn’t Enough - Yahoo Finance Australia
ISRG Looks 41.7% Undervalued on GF Value™ as Competition Heats U - GuruFocus
Intuitive Surgical rebounds as Street sees strength despite J&J competition (ISRG:NASDAQ) - Seeking Alpha
The ACA Coverage Debate Just Became a $50 Billion Question for Intuitive Surgical - Yahoo! Finance Canada
Intuitive Collaborates with Deion “Coach Prime” Sanders to Raise Patient Awareness of Surgical Options - markets.businessinsider.com
Intuitive, Deion Sanders Team Up for Surgical Awareness - Medical Product Outsourcing
Intuitive Surgical stock trades near record territory as robotic surgery growth supports valuation - Ad-hoc-news.de
Intuitive partners with Coach Prime to boost pa... - Pluang
After a Bladder Cancer Diagnosis, Coach Prime Shares His Surgery Choice - Stock Titan
ISRG|Intuitive Surgical Inc|Price:356.770|Chg%:+19.270 - TradingKey
J&J Ottava FDA Clearance Breaks da Vinci’s Two-Decade Soft-Tissue Monopoly - Tech Times
Is Intuitive’s AI-Driven Strategy and ESOP Shelf Registration Altering The Investment Case For Intuitive Surgical (ISRG)? - simplywall.st
Intuitive Surgical, Inc. Revenue Breakdown – TURQUOISE:ISRGN - TradingView
Intuitive Surgical stock rises on steady da Vinci demand - AD HOC NEWS
Intuitive Surgical Has Lost 45% From Its High. J&J’s New Robot Is Only Part of Why - TIKR.com
Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo - Yahoo Finance
Daiwa Securities Adjusts Price Target on Intuitive Surgical to $360 From $530, Maintains Outperform Rating - marketscreener.com
Intuitive Surgical to Demonstrate Telerobotic Surgery Live at SRS - Medical Device and Diagnostic industry
Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing? - Trefis
Medtech Stocks Have Gotten Slammed. Why Abbott, Danaher, 4 More Are Bargains. - Barron's
Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical - Yahoo Finance
Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG) - The Globe and Mail
Intuitive Surgical stock holds near record levels on strong margins - Ad-hoc-news.de
ISRG|Intuitive Surgical Inc|Price:341.000|Chg%:+3.500 - TradingKey
Intuitive Surgical, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Moomoo
Eli Lilly and Intuitive Surgical Are Healthcare Stocks Worth Buying, Thanks to Strong Fundamentals - NAI500
Intuitive Surgical Confronts Rising Risks From Unauthorized da Vinci and Ion Parts and Service - The Globe and Mail
2 Top Growth Stocks to Buy Right Now Without Any Hesitation - The Motley Fool
Intuitive Surgical (ISRG) Earnings Beat Keeps Its Valuation Narrative In Focus - simplywall.st
Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors - MarketWatch
J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock. - Yahoo Finance
인튜이티브 서지컬 (ISRG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
인튜이티브 서지컬 주식 (ISRG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jul 30 '26 |
Sale |
346.83 |
28 |
9,711 |
1,294 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jul 28 '26 |
Sale |
365.58 |
28 |
10,236 |
1,350 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jul 29 '26 |
Sale |
360.21 |
28 |
10,086 |
1,322 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jul 27 '26 |
Sale |
344.00 |
28 |
9,632 |
1,378 |
| Rosa David J. | Chief Executive Officer (CEO) |
Jul 10 '26 |
Option Exercise |
0.00 |
1,910 |
0 |
247,803 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 12 '26 |
Sale |
414.13 |
25 |
10,353 |
1,406 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 11 '26 |
Sale |
412.16 |
23 |
9,480 |
1,431 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 10 '26 |
Sale |
424.14 |
23 |
9,755 |
1,454 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 09 '26 |
Sale |
421.13 |
23 |
9,686 |
1,477 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 08 '26 |
Sale |
420.12 |
23 |
9,663 |
1,500 |
0.12%
3.26%
자본화:
|
볼륨(24시간):